Antiviral treatment of COVID-19

S Yavuz, S Ünal - Turkish journal of medical sciences, 2020 - journals.tubitak.gov.tr
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …

An update of anti-viral treatment of COVID-19.

S ŞİMŞEK YAVUZ… - Turkish journal of …, 2021 - search.ebscohost.com
Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a
large number of drugs have been evaluated since the beginning of the pandemic, and many …

Literature-based review of the drugs used for the treatment of COVID-19

M Venkatasubbaiah, PD Reddy… - … medicine research and …, 2020 - Elsevier
COVID-19 is primarily a respiratory disease caused by a newly discovered SARS-CoV-2
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …

Anti COVID-19 drugs: need for more clinical evidence and global action

Z Khan, Y Karataş, H Rahman - Advances in therapy, 2020 - Springer
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …

[HTML][HTML] Antiviral therapy in management of COVID-19: a systematic review on current evidence

M Yousefifard, A Zali, KM Ali… - Archives of academic …, 2020 - ncbi.nlm.nih.gov
Background: The purpose of the current systematic review is to evaluate the efficacy of
antiviral therapies in treatment of COVID-19. In addition, clinical trials on the efficacy of …

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review

A Wadaa-Allah, MS Emhamed, MA Sadeq… - Annals of …, 2021 - Taylor & Francis
To date, there is no final FDA-approved treatment for COVID-19. There are thousands of
studies published on the available treatments for COVID-19 virus in the past year. Therefore …

Recent progress of antiviral therapy for coronavirus disease 2019

M Zhao, J Zhang, H Li, Z Luo, J Ye, Y Xu… - European journal of …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has become a global public
health crisis, for which antiviral treatments are considered mainstream therapeutic …

Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis

M Wang, T Wu, Z Zuo, Y You, X Yang… - BMJ supportive & …, 2021 - spcare.bmj.com
Background Because of the lack of vaccination, it is urgent to find effective antiviral agents
for COVID-19 treatment. Method Online databases were searched for articles published …